Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab by Baraliakos, Xenofon et al.
113
Available online http://arthritis-research.com/content/7/3/113
After publication of this work [1], we noted that we
inadvertently failed to include the complete list of all co-
authors. The full list of authors has now been added and the
Authors’ contributions and Competing interests section
modified accordingly.
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